Cargando…
Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a highly malignant neoplasm. DNA-damaging drugs, such as cisplatin (CDDP) and 5-fluorouracil (5-FU), are most frequently used in preoperative chemotherapy for ESCC. However, the response to preoperative chemotherapy varies among patients. p53,...
Autores principales: | Izutsu, Masahiro, Domoto, Takanori, Kamoshida, Shingo, Ohsaki, Hiroyuki, Matsuoka, Hiroshi, Umeki, Yusuke, Shiogama, Kazuya, Hirayama, Masaya, Suda, Koichi, Uyama, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976339/ https://www.ncbi.nlm.nih.gov/pubmed/35365176 http://dx.doi.org/10.1186/s12957-022-02571-9 |
Ejemplares similares
-
Docetaxel+Cisplatin+5-FU (DCF) Therapy as a Preoperative Chemotherapy to Advanced Esophageal Squamous Cell Carcinoma: A Single-center Retrospective Cohort Study
por: Umeki, Yusuke, et al.
Publicado: (2023) -
Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy
por: Kawamura, Yuichiro, et al.
Publicado: (2016) -
p53 expression in repair/reactive renal tubular cells: A potential pitfall leading to a false‐positive diagnosis of urine cytology
por: Enomoto, Kaori, et al.
Publicado: (2021) -
Laparoscopic Surgery for Advanced Gastric Cancer: Current Status and Future Perspectives
por: Uyama, Ichiro, et al.
Publicado: (2013) -
Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007)